Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Carnitine/Organic Cation Transporter OCTN2 (Slc22a5) Is Responsible for Renal Secretion of Cephaloridine in Mice

Takashi Kano, Yukio Kato, Kimihiro Ito, Takuo Ogihara, Yoshiyuki Kubo and Akira Tsuji
Drug Metabolism and Disposition May 2009, 37 (5) 1009-1016; DOI: https://doi.org/10.1124/dmd.108.025015
Takashi Kano
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yukio Kato
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kimihiro Ito
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takuo Ogihara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshiyuki Kubo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akira Tsuji
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 37 no. 5 1009-1016
DOI 
https://doi.org/10.1124/dmd.108.025015
PubMed 
19220985

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received October 3, 2008
  • Accepted February 9, 2009
  • Published online April 17, 2009.

Article Versions

  • Earlier version (February 12, 2009 - 07:46).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Takashi Kano,
  2. Yukio Kato,
  3. Kimihiro Ito,
  4. Takuo Ogihara,
  5. Yoshiyuki Kubo and
  6. Akira Tsuji
  1. Division of Pharmaceutical Sciences, Graduate School of Natural Science and Technology, Kanazawa University, Kakumamachi, Kanazawa, Japan (T.K., Y.Ka., K.I., Y.Ku., A.T.); and Faculty of Pharmacy, Takasaki University of Health and Welfare, Takasaki, Gunma, Japan (T.O.)
  1. Address correspondence to:
    Akira Tsuji, Division of Pharmaceutical Sciences, Graduate School of Natural Science and Technology, Kanazawa University, Kakumamachi, Kanazawa 920-1192, Japan. E-mail: tsuji{at}kenroku.kanazawa-u.ac.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: February 2009 to May 2022

AbstractFullPdf
Feb 2009430101
Mar 20099032
Apr 2009361036
May 2009441728
Jun 2009241519
Jul 2009191923
Aug 2009221529
Sep 200914911
Oct 2009272218
Nov 2009171113
Dec 200928816
Jan 20104587
Feb 201032108
Mar 20104367
Apr 2010321110
May 2010292413
Jun 2010261713
Jul 2010201516
Aug 2010221311
Sep 201051414
Oct 2010193334
Nov 2010291413
Dec 201020139
Jan 2011181910
Feb 2011171714
Mar 2011171914
Apr 201192115
May 2011232412
Jun 201114105
Jul 2011111112
Aug 2011201011
Sep 2011181710
Oct 201123115
Nov 2011281916
Dec 201119339
Jan 2012202415
Feb 201216129
Mar 2012342017
Apr 2012301316
May 2012292018
Jun 2012232912
Jul 2012192917
Aug 2012262113
Sep 201215209
Oct 2012311521
Nov 2012273515
Dec 2012322013
Jan 2013473214
Feb 2013321512
Mar 2013301511
Apr 2013322611
May 201335228
Jun 201322116
Jul 20131563
Aug 201328126
Sep 201325134
Oct 201320144
Nov 201331125
Dec 201334187
Jan 201418284
Feb 2014122513
Mar 201464010
Apr 201419292
May 201412216
Jun 201418147
Jul 20141094
Aug 20141691
Sep 201417182
Oct 201471412
Nov 201410152
Dec 201410145
Jan 201567279
Feb 20155231
Mar 201512285
Apr 201512193
May 20157229
Jun 201511299
Jul 201514188
Aug 201517322
Sep 201518252
Oct 20157242
Nov 20157171
Dec 201510105
Jan 20167118
Feb 2016123
Mar 201661516
Apr 20167219
May 201621010
Jun 20168128
Jul 201631319
Aug 201621113
Sep 201642019
Oct 20162236
Nov 201611745
Dec 201612949
Jan 2017019519
Feb 2017013216
Mar 201721154
Apr 201721148
May 201702713
Jun 201712610
Jul 20179153
Aug 20171359
Sep 201702967
Oct 201701285
Nov 20171329
Dec 20173379
Jan 20180175
Feb 20181345
Mar 201822310
Apr 20180283
May 20181326
Jun 20182255
Jul 20180316
Aug 20180386
Sep 20180372
Oct 20180686
Nov 20180743
Dec 201873160
Jan 20195645
Feb 20196321
Mar 20193032
Apr 20192236
May 20191848
Jun 20191340
Jul 2019901
Aug 2019900
Sep 20191904
Oct 20192062
Nov 20192220
Dec 20191522
Jan 20202053
Feb 20201352
Mar 20201411
Apr 20201606
May 2020282
Jun 2020711
Jul 2020412
Aug 20201004
Sep 20201120
Oct 20201422
Nov 20201101
Dec 20201314
Jan 20211097
Feb 20212434
Mar 20211232
Apr 20212021
May 20211752
Jun 20211643
Jul 20212013
Aug 20211620
Sep 20211042
Oct 20211732
Nov 20212545
Dec 20214233
Jan 20221222
Feb 20221120
Mar 2022924
Apr 2022881
May 2022822

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 37 (5)
Drug Metabolism and Disposition
Vol. 37, Issue 5
1 May 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Carnitine/Organic Cation Transporter OCTN2 (Slc22a5) Is Responsible for Renal Secretion of Cephaloridine in Mice
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Carnitine/Organic Cation Transporter OCTN2 (Slc22a5) Is Responsible for Renal Secretion of Cephaloridine in Mice

Takashi Kano, Yukio Kato, Kimihiro Ito, Takuo Ogihara, Yoshiyuki Kubo and Akira Tsuji
Drug Metabolism and Disposition May 1, 2009, 37 (5) 1009-1016; DOI: https://doi.org/10.1124/dmd.108.025015

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Carnitine/Organic Cation Transporter OCTN2 (Slc22a5) Is Responsible for Renal Secretion of Cephaloridine in Mice

Takashi Kano, Yukio Kato, Kimihiro Ito, Takuo Ogihara, Yoshiyuki Kubo and Akira Tsuji
Drug Metabolism and Disposition May 1, 2009, 37 (5) 1009-1016; DOI: https://doi.org/10.1124/dmd.108.025015
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Role of Human MSRA on Sulindac Activation
  • Determination of Acyl-, O-, and N-Glucuronide
  • Uptake as the RDS in Pevonedistat Hepatic Clearance
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics